Month: January 2021
-
Summary – MHRA updated guidance on pharmacovigilance procedures
The United Kingdom (UK) formally left the European Union (EU) on 31 January 2020 and since that time has been in a transition ‘phase’. This transitionary phase, which is due to expire on 31 December 2020, has given pharmaceutical companies time to make the necessary changes to ensure that their centrally and nationally authorised medicines…
-
Drug Safety Alerts – January
Warfarin and other Anticoagulants: Monitoring of Patients during the COVID-19 Pandemic Methotrexate Once Weekly for Autoimmune Diseases: New Measures to Reduce Risk of Fatal Overdose due to Inadvertent Daily Instead of Weekly Dosing Nivolumab (Genetical Recombination): Revision of Precautions Tecentriq (Atezolizumab): A New Identified Risk of Severe Cutaneous Adverse Reactions Montelukast: Increased Risk of Neuropsychiatric…